<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2124">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04360707</url>
  </required_header>
  <id_info>
    <org_study_id>7766</org_study_id>
    <nct_id>NCT04360707</nct_id>
  </id_info>
  <brief_title>Solid Organ Transplant Recipients With SARS-CoV-2 French Registry</brief_title>
  <acronym>TX-COVID</acronym>
  <official_title>Clinical Presentation and Incidence of SARS-CoV-2 Infection in Different Cohorts of Solid Organ Transplant Patients and Follow-up in France</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with comorbid condition are known to be at high risk of severe forms of Covid-19. It
      is highly probable that immunocompromised patients like solid organ transplant (SOT)
      recipients are also at risk of severe forms of Covid-19. For this purpose, The investigators
      conducted a nationwide multicentric and multiorgan Registry to collect data about all French
      SOT recipients who develop a SARS-CoV-2 infection. The aim is to describe the clinical,
      biological and virological characteristics of these patients and to give information about
      evolution and prognosis of these particular population
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 8, 2020</start_date>
  <completion_date type="Anticipated">April 8, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 8, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Presentation and Incidence of Covid-19 Infection in Different Cohorts of Solid Organ Transplant Patients</measure>
    <time_frame>From 1st March 2020 to 1st March 2021</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>SARS-CoV-2</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All Solid Organ Transplant recipients with a functioning graft and a high suspicion or a
        confirmed SARS-CoV-2 infection
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All Solid Organ Transplant recipients with a functioning graft and a high suspicion or
             a confirmed SARS-CoV-2 infection

          -  Adult and pediatric

        Exclusion Criteria:

        - There are no exclusion criteria, except for the patient's explicit refusal to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sophie CAILLARD, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Service de Néphrologie et Transplantation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sophie CAILLARD, MD, PhD</last_name>
    <phone>33 3 69 55 13 20</phone>
    <email>sophie.caillard@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saïd CHAYER, PhD, HDR</last_name>
    <phone>33 3 88 11 66 90</phone>
    <email>said.chayer@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de Néphrologie et Transplantation</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie CAILLARD, MD, PhD</last_name>
      <phone>33 3 69 55 13 20</phone>
      <email>sophie.caillard@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Samira FAFI-KREMER, MD, PhD</last_name>
      <phone>33 3 69 55 14 38</phone>
      <email>samira.fafi-kremer@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Sophie CAILLARD, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Samira FAFI-KREMER, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gabriela GAUTIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 22, 2020</study_first_submitted>
  <study_first_submitted_qc>April 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2020</study_first_posted>
  <last_update_submitted>April 30, 2020</last_update_submitted>
  <last_update_submitted_qc>April 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SARS-CoV-2</keyword>
  <keyword>Covid-19</keyword>
  <keyword>Solid Organ transplantation</keyword>
  <keyword>Incidence</keyword>
  <keyword>Prognosis</keyword>
  <keyword>Cellular response</keyword>
  <keyword>Humoral Response</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

